Who have Obstruction of the ureteropelvic junction with Miralax - from FDA reports

There is no Obstruction of the ureteropelvic junction reported by people who take Miralax yet. This review analyzes which people have Obstruction of the ureteropelvic junction with Miralax. It is created by eHealthMe based on reports from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Feb, 23, 2019

No report is found.

Do you have Obstruction of the ureteropelvic junction while taking Miralax?

You are not alone:

Related studies

Miralax

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. (latest outcomes from Miralax 47,992 users)

Obstruction Of The Ureteropelvic Junction

Obstruction of the ureteropelvic junction (a blockage in the area that connects the renal pelvis (part of the kidney) to one of the tubes (ureters) that move urine) has been reported by people with rheumatoid arthritis (latest reports from 2 Obstruction of the ureteropelvic junction patients).

Browse all side effects of Miralax

a b c d e f g h i j k l m n o p q r s t u v w x y z

Compare Miralax to similar drugs:

What would happen?

Predict new side effects and undetected conditions when you take Miralax and have Obstruction of the ureteropelvic junction

Recent updates

Recent general studies

Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.